Back to 
Macquarie Group Ltd.
Macquarie Group Ltd.
KPTI
Showing 3 of 26 quarters
Position history for Macquarie Group Ltd.'s holdings in Karyopharm Therapeutics Inc.
As of its Q4 2024 13F, Macquarie Group held 500,000 shares of KPTI (Karyopharm Therapeutics), worth $338,000. Macquarie Group's 13F filings listed KPTI from Q4 2018 to Q4 2024, 25 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$415,000
Total Shares Change
-500,000
Quarter-by-Quarter History
Other major holders of KPTI: Avoro Capital Advisors LLC, State Street Corp.